Bill Ackman

Bill Ackman

Last Update: 07-08-2016

Number of Stocks: 9
Number of New Stocks: 1

Total Value: $8,853 Mil
Q/Q Turnover: 5%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Bill Ackman' s Profile & Performance

Profile

William Ackman, co-investment manager for hedge-fund group Gotham Partners LP, formed Pershing Square in November 2003 with $54 million raised from three investors. Ackman got his start in the real estate business, where he worked for his father prior to starting Gotham.

Investing Philosophy

Bill Ackman is an activist investor. He buys the common stocks of public companies, and pushes for changes so that the market can realize the values of the companies. Ackman buys stocks trading at a discount, and sells when the companies reach their appraised value.

Total Holding History

Performance of Pershing Square, L.P.

YearReturn (%)S&P500 (%)Excess Gain (%)
201436.913.6923.2
20139.732.39-22.7
201213.316-2.7
3-Year Cumulative70.2 (19.4%/year)74.6 (20.4%/year)-4.4 (-1%/year)
2011-1.12.11-3.2
201029.715.0614.6
5-Year Cumulative118.3 (16.9%/year)105.1 (15.5%/year)13.2 (1.4%/year)
200940.626.4614.1
2008-13-3724.0
2007225.4916.5
200622.515.796.7
200539.94.9135.0
10-Year Cumulative458.2 (18.8%/year)109.4 (7.7%/year)348.8 (11.1%/year)
200442.610.8831.7

Top Ranked Articles

The Battle of the Billionaire Gurus – and the Future of Herbalife Did Herbalife operate a pyramid scheme that cheated its independent distributors, or not? Two gurus put their money, a lot of money, on opposite sides of the claim. Here’s who won. . . .
Two of the great investing names of our times, Carl Icahn (Trades, Portfolio) of Icahn Capital Management LP and Bill Ackman (Trades, Portfolio) of Pershing Square Capital Management, L.P. are both friends and bitter rivals. That rivalry arises out of their diametrically opposed views about Herbalife, the nutritional supplements company. And more specifically, about the compensation of independent distributors who sell those products to consumers. Read more...
Bill Ackman Comments on Herbalife in 2nd Quarter Conference Call Activist investor with short position in Herbalife reacts to its settlement with FTC
During his conference call this morning, Bill Ackman (Trades, Portfolio) presented on Herbalife’s settlement with the Federal Trade Commission. After summarizing background information of the case, Ackman discussed the implications of the settlement based on three complaint categories. Read more...
Bill Ackman’s Portfolio Returns Diminish as Stock Prices Decline An introduction to the activist investor and his portfolio, conference call is scheduled for tomorrow
Activist investor Bill Ackman (Trades, Portfolio) founded the Pershing Square Capital Management Fund in 2003. With a simple investing approach, the fund manager seeks value by buying stocks at cheap prices and selling them once they reach their fair values. Despite having high returns in 2014, the fund experienced poor returns as of July 2016. Read more...
Learn from Bill Ackman’s Mistakes The poor performance of Bill Ackman's Pershing Square Holdings exhibits common mistakes displayed by investors.
Learn from Bill Ackman (Trades, Portfolio)’s Mistakes Read more...
Bill Ackman's Herbalife Settles With FTC, Stock Is Undervalued Company hurting short-seller appears attractive
Bill Ackman (Trades, Portfolio)’s Pershing Square sustained another strike Friday when a long-time short, nutrition direct seller Herbalife (NYSE:HLF), settled with the FTC for $200 million if it made certain changes to its business model, finally laying to rest his allegation that it is a pyramid scheme. Read more...
» More Bill Ackman Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

The Battle of the Billionaire Gurus – and the Future of Herbalife Did Herbalife operate a pyramid scheme that cheated its independent distributors, or not? Two gurus put their money, a lot of money, on opposite sides of the claim. Here’s who won. . . . Carl Icahn, Bill Ackman - The Battle Of The Billionaire Gurus – And The Future Of Herbalife
Two of the great investing names of our times, Carl Icahn (Trades, Portfolio) of Icahn Capital Management LP and Bill Ackman (Trades, Portfolio) of Pershing Square Capital Management, L.P. are both friends and bitter rivals. That rivalry arises out of their diametrically opposed views about Herbalife, the nutritional supplements company. And more specifically, about the compensation of independent distributors who sell those products to consumers. More...

CARL ICAHN, BILL ACKMAN, PERSHING SQUARE, FTC, HERBALIFE


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Bill Ackman Comments on Herbalife in 2nd Quarter Conference Call Activist investor with short position in Herbalife reacts to its settlement with FTC Bill Ackman,Carl Icahn - Bill Ackman Comments On Herbalife In 2nd Quarter Conference Call
During his conference call this morning, Bill Ackman (Trades, Portfolio) presented on Herbalife’s settlement with the Federal Trade Commission. After summarizing background information of the case, Ackman discussed the implications of the settlement based on three complaint categories. More...

BILL ACKMAN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Bill Ackman’s Portfolio Returns Diminish as Stock Prices Decline An introduction to the activist investor and his portfolio, conference call is scheduled for tomorrow Bill Ackman - Bill Ackman’s Portfolio Returns Diminish As Stock Prices Decline
Activist investor Bill Ackman (Trades, Portfolio) founded the Pershing Square Capital Management Fund in 2003. With a simple investing approach, the fund manager seeks value by buying stocks at cheap prices and selling them once they reach their fair values. Despite having high returns in 2014, the fund experienced poor returns as of July 2016. More...

BILL ACKMAN


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Pershing Square's Statement Regarding Herbalife Bill Ackman discusses Herbalife's settlement with US regulators Bill Ackman - Pershing Square's Statement Regarding Herbalife
New York, July 15, 2016 //- Pershing Square Capital Management, L.P. (“Pershing Square”) today released the following statement: More...

  • Currently 3.75/5

Rating: 3.8/5 (4 votes)

Learn from Bill Ackman’s Mistakes The poor performance of Bill Ackman's Pershing Square Holdings exhibits common mistakes displayed by investors. Bill Ackman, Warren Buffett, Chuck Royce - Learn From Bill Ackman’s Mistakes
Learn from Bill Ackman (Trades, Portfolio)’s Mistakes More...

ACKMAN, PERSHING SQUARE


  • Currently 2.00/5

Rating: 2.0/5 (4 votes)

Bill Ackman's Herbalife Settles With FTC, Stock Is Undervalued Company hurting short-seller appears attractive Bill Ackman - Bill Ackman's Herbalife Settles With FTC, Stock Is Undervalued
Bill Ackman (Trades, Portfolio)’s Pershing Square sustained another strike Friday when a long-time short, nutrition direct seller Herbalife (NYSE:HLF), settled with the FTC for $200 million if it made certain changes to its business model, finally laying to rest his allegation that it is a pyramid scheme. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Bill Ackman: Herbalife Bilking People, NBC Helping Valeant Short-Seller Make Money Ackman discusses Valeant and Herbalife short in interview Bill Ackman - Bill Ackman: Herbalife Bilking People, NBC Helping Valeant Short-Seller Make Money
Bill Ackman (Trades, Portfolio) spoke to CNBC this morning on the phone. He talked about the recent public short seller attack by Andrew Left on his holding Valeant (NYSE:VRX) and why he stayed short Herbalife (NYSE:HLF). More...

  • Currently 4.00/5

Rating: 4.0/5 (1 vote)

Ackman Sells Nearly a Quarter of Stake in Zoetis Guru trims position by more than 6 million shares Bill Ackman - Ackman Sells Nearly A Quarter Of Stake In Zoetis
Bill Ackman (Trades, Portfolio) of Pershing Square Capital Management LP reduced his stake in Zoetis Inc. (NYSE:ZTS) for the second time this year with the sale of 6,081,841 shares for $47.69 per share on July 7. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

CEO of Valeant Joseph Papa Makes $5 Million Insider Buy Papas' pay is highly tied to stock price Bill Ackman - CEO Of Valeant Joseph Papa Makes $5 Million Insider Buy
The CEO of Valeant Pharmaceuticals (NYSE:VRX), Joseph Papa, has dropped almost $5 million on 202,000 shares of the company, according to insider filings. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Ackman Pared His Stake in Mondelez International In 1st Quarter Guru invested in 5 million shares of Valeant Bill Ackman - Ackman Pared His Stake In Mondelez International In 1st Quarter
Bill Ackman (Trades, Portfolio) of Pershing Square Capital Management LP made transactions in four stocks in the first quarter, reducing his holdings in two and adding to his holdings in the others. More...

  • Currently 5.00/5

Rating: 5.0/5 (8 votes)

Bill Ackman Asks Charlie Munger to Be Nicer About Valeant New documents show correspondence between Ackman, Munger and Buffett Bill Ackman,Charlie Munger - Bill Ackman Asks Charlie Munger To Be Nicer About Valeant
Some correspondence between Bill Ackman (Trades, Portfolio), a major Valeant (NYSE:VRX) shareholder, Warren Buffett (Trades, Portfolio) and Charlie Munger (Trades, Portfolio) surfaced this week in a slew of documents the U.S. Senate committee investigating drug price gouging has released. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Pershing Square's, and Ackman’s, Less Talked About Positions Guru's low-profile stakes include Air Products, Mondelez, Canadian Pacific Bill Ackman - Pershing Square's, And Ackman’s, Less Talked About Positions
If there’s one hedge fund that has grabbed more headlines than any other this quarter it's Pershing Square, and specifically, its CEO Bill Ackman (Trades, Portfolio). The activist investor has long drawn the spotlight, famously with his so-called billion-dollar short position in Herbalife Ltd. (NYSE:HLF) and, more recently, his troubled long in Valeant Pharmaceuticals International Inc. (NYSE:VRX). More...

HEDGE FUNDS, LONG, PERSHING, ACKMAN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Bill Ackman Slashes Position in Zoetis Company's financial results have been struggling over the past 12 months Bill Ackman,George Soros,Vanguard Health Care Fund - Bill Ackman Slashes Position In Zoetis
Guru Bill Ackman (Trades, Portfolio) and founder of Pershing Square Capital Management LP slashed his position in Zoetis Inc. (NYSE:ZTS) on May 9. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Bill Ackman Comments on Zoetis Inc. Guru stock highlight
Zoetis (NYSE:ZTS) is the only large, independent, publicly traded animal health company in the world. The company has a market capitalization of ~$23 billion and $5 billion in revenue. The Pershing Square funds currently own a 5.0% economic stake in the company, down from 8.6% as a result of a recent block sale. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Bill Ackman Comments on Restaurant Brands International Guru stock highlight
Restaurant Brands (NYSE:QSR) reported another strong quarter of underlying earnings with its results for the first quarter of 2016. The company continues to deliver strong same-store-sales growth and net unit growth at both concepts and continues to improve Tim Hortons’ cost structure. More...

  • Currently 5.00/5

Rating: 5.0/5 (2 votes)

Bill Ackman Comments on Platform Specialty Products Corp Guru stock highlight
Platform (NYSE:PAH) reported modestly improved underlying earnings due to strong cost synergies from its recent acquisitions, which were offset by weakness in several key end markets and an increase in corporate costs. Reported earnings were lower than the prior year due to significant headwinds from FX. Still, earnings beat expectations leading to a substantial increase in PAH’s stock price. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Bill Ackman Comments on Nomad Guru stock highlight
Nomad (NYSE:NOMD)’s acquisitions of Iglo and Findus created the leading branded frozen foods business inEurope, ~2.7 times the next largest competitor. It is the market leader in the UK, Italy, Germany, France, Spain, and Sweden. The business is stable, high-margin, and cash-flow generative with low capex requirements and modest cash taxes. Nomad purchased both assets for a total of €3.3 billion or ~8 times EBITDA post-synergies. In 2015, pro forma revenue was €2.1 billion, with €345million EBITDA and €0.95 EPS ($1.06), excluding synergies which are currently estimated at €43 to €48 million. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Bill Ackman Comments on Mondelez Guru stock highlight
We continue to believe that the opportunity for productivity improvement and margin expansion at Mondelez (NASDAQ:MDLZ) is significant. In February, the company announced a 2018 operating margin target of 17% to 18%. This target reflects some of the steps the company has taken over the last several years to improve its supply chain, reduce portfolio complexity, and rationalize overhead while increasing advertising and promotion. While we believe that the business is capable of higher margins, if Mondelez were to only achieve management’s target, the business would be worth significantly more than its current public market valuation. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Bill Ackman Comments on Herbalife Guru stock highlight
On May 5th, Herbalife (NYSE:HLF) reported improved financial performance for the first quarter of the year and updated their regulatory disclosures as follows: More...

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK